中国处方药
中國處方藥
중국처방약
CHINA PRESCRIPTION DRUG
2015年
4期
16-17
,共2页
β 受体阻滞剂%慢性收缩性心力衰竭%效果
β 受體阻滯劑%慢性收縮性心力衰竭%效果
β 수체조체제%만성수축성심력쇠갈%효과
β-blockers%Chronic systolic heart failure%Effect
目的：评价β受体阻滞剂在慢性收缩性心力衰竭中的治疗效果。方法选取2011年～2012年收治的120例慢性收缩性心力衰竭患者，分成观察组和对照组，每组60例，对照组给予常规治疗，观察组在进行常规治疗的基础上给予β受体阻滞剂治疗，在治疗前、治疗后对患者的心率、射血分数等进行比较。结果观察组患者治疗后，左室舒张末期容积、左室收缩末期容积均明显降低，并明显低于对照组患者，组间比较差异具有统计学意义（P ＜0.05）。结论严格掌握使用β受体阻滞剂指征，合理使用该类药物对老年收缩性心力衰竭具有较良好的效果。
目的：評價β受體阻滯劑在慢性收縮性心力衰竭中的治療效果。方法選取2011年～2012年收治的120例慢性收縮性心力衰竭患者，分成觀察組和對照組，每組60例，對照組給予常規治療，觀察組在進行常規治療的基礎上給予β受體阻滯劑治療，在治療前、治療後對患者的心率、射血分數等進行比較。結果觀察組患者治療後，左室舒張末期容積、左室收縮末期容積均明顯降低，併明顯低于對照組患者，組間比較差異具有統計學意義（P ＜0.05）。結論嚴格掌握使用β受體阻滯劑指徵，閤理使用該類藥物對老年收縮性心力衰竭具有較良好的效果。
목적：평개β수체조체제재만성수축성심력쇠갈중적치료효과。방법선취2011년～2012년수치적120례만성수축성심력쇠갈환자，분성관찰조화대조조，매조60례，대조조급여상규치료，관찰조재진행상규치료적기출상급여β수체조체제치료，재치료전、치료후대환자적심솔、사혈분수등진행비교。결과관찰조환자치료후，좌실서장말기용적、좌실수축말기용적균명현강저，병명현저우대조조환자，조간비교차이구유통계학의의（P ＜0.05）。결론엄격장악사용β수체조체제지정，합리사용해류약물대노년수축성심력쇠갈구유교량호적효과。
Objective To observe and evaluate the effect of β-blocker therapy in patients with chronic systolic heart failure. Methods 120 cases of patients with chronic systolic heart failure treated in our hospital from 2011 to 2012 were selected and divided into observation group and control group,60 cases of each. Then control group patients received conventional treatment,and the observed patients during the conventional treatment were given β-blocker therapy. After treatment,the patient's heart rate,ejection fraction were compared. Results The observation group patients,left ventricular end-diastolic volume and left ventricular end-systolic volume were significantly reduced,and significantly lower than the patients in the control group,Comparing the differences between the two groups was statistically significant(P < 0.05). Conclusion Strict control β-blockers usage can improve elderly systolic heart failure with relatively good results,which is worthy of clinical application.
